6th Circ. Affirms Dismissals From Novartis MDL
A federal appellate court has affirmed the dismissal of a number of lawsuits from the multidistrict litigation alleging that Novartis Pharmaceutical Corp.'s bone cancer drugs Aredia and Zometa cause a condition...To view the full article, register now.
Already a subscriber? Click here to view full article